Composition for preventing and treating degenerative brain disease using novel lactic acid bacteria
AssigneeWedea Inc.
InventorsSu Yeon Jo, Se Hyeok Min, Seok Jin Yun, Do Hee Kim
Life of this patent
Estimating the term…
Abstract
Provided is a composition containing Lactobacillus reuteri ELF corresponding to a novel lactic acid bacteria strain and 5-aminolevulinic acid. The composition may be significantly effective to prevent and treat degenerative brain disease and have excellent anti-obesity and anti-diabetes effects, such that the present invention may provide various pharmaceutical composition, health foods, and the like, using the same.
Claims4
A method of reducing tau protein expression and β-amyloid plaque formation comprising administering to a subject in need thereof a composition comprising a pure culture of Lactobacillus reuteri ELF, deposited under Accession Number KCTC 13154BP.
A method of increasing cytochrome c oxidase (COX) activity in brain mitochondria, comprising administering to a subject in need thereof a composition comprising a pure culture of Lactobacillus reuteri ELF, deposited under Accession Number KCTC 13154BP and 5-aminolevulinic acid.
Dependencies are inferred from the claim text.